Slideshow
Author(s):
A host of neuropsychiatric disorders are intrinsic to Parkinson disease or occur as a complication of the dopaminergic therapies. Here's what to look for.
NeurologyLive® Friday 5 — February 14, 2024
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
Optimizing Parkinson Disease Care With Newly Approved Continuous Infusion Therapy
Neurology Unwrapped: 2024’s Most Intriguing Conversations
New Investigator-Initiated Study to Test CYR-064 for Hyposmia in Parkinson Disease
NeurologyLive® Friday 5 — February 7, 2024